Metronidazole Benzoate 80 mg/mL Oral Suspension

This suspension ensures a uniform distribution of the active ingredient, metronidazole benzoate, throughout the liquid medium, allowing for precise dosing and easy administration, especially for those who have difficulty swallowing tablets or capsules.

Metronidazole benzoate is a derivative of metronidazole, an antibiotic and antiprotozoal agent widely used to treat infections caused by anaerobic bacteria and certain parasites. By disrupting the DNA synthesis of susceptible organisms, metronidazole effectively eradicates the infection, leading to symptom resolution and preventing further complications.

For patients, this oral suspension offers a palatable and convenient treatment option. The liquid form is especially beneficial for pediatric patients, the elderly, or anyone with swallowing difficulties. Accurate dosing is made simpler with this formulation, ensuring that patients receive the exact amount prescribed by their healthcare provider. It is important to shake the bottle well before each use to ensure the medication is properly mixed.

Healthcare providers may find this formulation advantageous when individualized dosing is required or when patient adherence to solid dosage forms is a concern. The 80 mg/mL concentration allows for flexible dosing adjustments based on the patient's weight, age, and specific medical condition. The uniformity of the suspension ensures consistent therapeutic effects with each dose administered.

Patients should be advised to complete the full course of therapy as prescribed, even if symptoms improve earlier, to prevent the risk of recurrence or resistance. Common side effects may include nausea, a metallic taste, or gastrointestinal discomfort. Patients should avoid consuming alcohol during treatment and for at least 48 hours after the last dose due to the potential for adverse reactions like flushing, abdominal cramps, and nausea.

If you have any questions, reach out to us.

Metronidazole Benzoate 80 mg/mL Oral Suspension is a liquid dosage form designed to provide a homogeneous mixture for administration, ensuring that the active ingredient is dispersed uniformly throughout the liquid medium. This formulation is commonly used to treat a variety of infections caused by anaerobic bacteria and certain parasites, including bacterial vaginosis, trichomoniasis, and certain types of gastrointestinal infections. It is crucial for both patients and prescribers to be aware of potential drug interactions when using this formulation to ensure appropriate treatment.

Metronidazole is known to interact with several medications, which can either potentiate its effects or diminish its efficacy. One of the most significant interactions is with alcohol. Patients should be advised to avoid alcohol consumption during treatment and for at least 48 hours after the last dose, as the combination can lead to a disulfiram-like reaction, characterized by nausea, vomiting, flushing, and tachycardia.

Another important interaction is with warfarin and other oral anticoagulants. Metronidazole can enhance the anticoagulant effect of warfarin, increasing the risk of bleeding. It is recommended that the prothrombin time or INR be closely monitored, and dosage adjustments of the anticoagulant may be necessary during and after treatment with metronidazole.

Metronidazole may also interact with lithium, potentially leading to increased lithium levels and toxicity. Patients on lithium therapy should have their serum lithium levels monitored, and dosage adjustments may be required to prevent adverse effects.

Additionally, metronidazole can interact with certain anticonvulsants such as phenytoin and phenobarbital. These medications can increase the metabolism of metronidazole, potentially reducing its effectiveness. Conversely, metronidazole can inhibit the metabolism of phenytoin, leading to increased phenytoin levels and potential toxicity. Monitoring of drug levels and clinical response is advised when these drugs are used concurrently.

Patients taking cyclosporine should also be monitored closely, as metronidazole can increase cyclosporine levels, raising the risk of nephrotoxicity. Regular monitoring of cyclosporine levels and renal function is recommended.

For patients on busulfan, caution is advised as metronidazole can increase busulfan levels, potentially leading to toxicity. Alternative antimicrobial therapy should be considered if possible.

It is essential for healthcare providers to review a patient's current medication list for potential interactions before prescribing Metronidazole Benzoate 80 mg/mL Oral Suspension. Patients should be encouraged to inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements. If you have any questions or concerns about drug interactions with this formulation, please reach out to us for further assistance.

Metronidazole Benzoate 80 mg/mL Oral Suspension is a compounded liquid formulation designed to deliver the active ingredient, metronidazole, in a palatable and easily administrable form. Metronidazole is an antibiotic and antiprotozoal medication that works by inhibiting nucleic acid synthesis in microorganisms, leading to their death.

In this oral suspension, metronidazole benzoate is uniformly dispersed throughout a liquid medium, ensuring a homogeneous mixture. This uniformity is crucial for accurate dosing, as it allows for consistent delivery of the medication with each administration. The liquid form is particularly beneficial for patients who may have difficulty swallowing tablets or capsules, such as pediatric or geriatric patients, or those with certain medical conditions that impair swallowing.

Metronidazole is commonly used to treat infections caused by anaerobic bacteria, which thrive in environments with little to no oxygen, such as the gastrointestinal tract, skin, and oral cavity. By disrupting the DNA synthesis of these pathogens, metronidazole effectively halts their growth and replication, allowing the body's immune system to eliminate the infection.

For prescribers, the 80 mg/mL concentration of this oral suspension allows for flexible dosing tailored to the specific needs of the patient, based on the severity of the infection and the patient's weight and overall health. This flexibility is particularly important in pediatric cases, where precise dosing is critical to ensure efficacy while minimizing potential side effects.

Patients should be advised to shake the bottle well before each use to ensure the medication is properly mixed. It is also important to adhere to the prescribed dosing schedule and complete the full course of treatment, even if symptoms improve, to prevent the development of antibiotic resistance.

If you have any questions about Metronidazole Benzoate 80 mg/mL Oral Suspension or its use in treating specific infections, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need.

Metronidazole Benzoate 80 mg/mL Oral Suspension is primarily used for the treatment of various infections caused by anaerobic bacteria and certain parasites. However, beyond its primary indications, this formulation may have other potential uses that could be beneficial in specific clinical scenarios. One such use is in the management of bacterial vaginosis, where metronidazole's efficacy against Gardnerella vaginalis can be advantageous. Although typically administered in other forms for this condition, the oral suspension may be considered in cases where patients have difficulty swallowing tablets or capsules, or when precise dosing adjustments are necessary.

Additionally, metronidazole has been explored for its anti-inflammatory properties, which may be useful in treating inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. In these conditions, the oral suspension form can provide a more tailored dosing regimen, potentially improving patient adherence and therapeutic outcomes. Furthermore, metronidazole's role in the eradication of Helicobacter pylori, a bacterium associated with peptic ulcer disease, highlights its versatility. While typically part of a combination therapy, the oral suspension could be utilized in patients requiring a liquid formulation due to swallowing difficulties or specific dosing needs.

For prescribers, it is important to consider the pharmacokinetics and patient-specific factors when opting for the oral suspension form of metronidazole benzoate. The liquid formulation allows for flexible dosing, which can be particularly beneficial in pediatric or geriatric populations, or in patients with renal or hepatic impairments where dose adjustments are critical. Patients should be informed about the potential side effects, such as gastrointestinal disturbances and a metallic taste, and advised to report any unusual symptoms promptly. As with any off-label use, careful consideration of the risk-benefit ratio is essential, and prescribers should remain informed about the latest clinical guidelines and evidence supporting these alternative uses.

If you have any questions or require further information about the use of Metronidazole Benzoate 80 mg/mL Oral Suspension, please reach out to us. Our team at Bayview Pharmacy is here to assist with any inquiries or concerns you may have regarding this formulation.